PhD20 Updated Safety and Efficacy from the Copanlisib CHRONOS-1 Trial in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma: Low Incidence of Late-Onset Severe Toxicities

dreyling m., santoro a., mollica l., leppa s., fallows g., lenz g., ...Daha Fazla

ASH, 6 - 14 Aralık 2017

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Ankara Üniversitesi Adresli: Evet